Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKrinsley, James S-
dc.contributor.authorChase, J Geoffrey-
dc.contributor.authorGunst, Jan-
dc.contributor.authorMartensson, Johan-
dc.contributor.authorSchultz, Marcus J-
dc.contributor.authorTaccone, Fabio S-
dc.contributor.authorWernerman, Jan-
dc.contributor.authorBohe, Julien-
dc.contributor.authorDe Block, Christophe-
dc.contributor.authorDesaive, Thomas-
dc.contributor.authorKalfon, Pierre-
dc.contributor.authorPreiser, Jean-Charles-
dc.identifier.citationCritical Care 2017; 21(1): 197-
dc.description.abstractGlucose management in intensive care unit (ICU) patients has been a matter of debate for almost two decades. Compared to intermittent monitoring systems, continuous glucose monitoring (CGM) can offer benefit in the prevention of severe hyperglycemia and hypoglycemia by enabling insulin infusions to be adjusted more rapidly and potentially more accurately because trends in glucose concentrations can be more readily identified. Increasingly, it is apparent that a single glucose target/range may not be optimal for all patients at all times and, as with many other aspects of critical care patient management, a personalized approach to glucose control may be more appropriate. Here we consider some of the evidence supporting different glucose targets in various groups of patients, focusing on those with and without diabetes and neurological ICU patients. We also discuss some of the reasons why, despite evidence of benefit, CGM devices are still not widely employed in the ICU and propose areas of research needed to help move CGM from the research arena to routine clinical use.-
dc.subjectNeurointensive care-
dc.titleContinuous glucose monitoring in the ICU: clinical considerations and consensus.-
dc.typeJournal Article-
dc.identifier.journaltitleCritical Care-
dc.identifier.affiliationDivision of Critical Care, Department of Medicine, Stamford Hospital, Columbia University College of Physicians and Surgeons, Stamford, CT, 06902, USA-
dc.identifier.affiliationDepartment of Intensive Care, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Anesthesia and Intensive Care Medicine, Karolinska University Hospital, Department of Physiology and Pharmacology, Karolinska Institutet, 171 77, Stockholm, Swedenen
dc.identifier.affiliationAcademic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlandsen
dc.identifier.affiliationDepartment of Intensive Care, Laboratory of Experimental Intensive Care and Anesthesia (L E I C A), Faculty of Tropical Medicine, Mahidol University, Mahidol-Oxford Research Unit (MORU), Bangkok, Thailanden
dc.identifier.affiliationDepartment of Mechanical Engineering, Centre for Bio-Engineering, University of Canterbury, Christchurch, 8140, New Zealand-
dc.identifier.affiliationClinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, 3000, Leuven, Belgium-
dc.identifier.affiliationDepartment of Intensive Care, Erasme Hospital, Université libre de Bruxelles, 1070, Brussels, Belgium-
dc.identifier.affiliationKarolinska University Hospital Huddinge & Karolinska Institutet, K32 14186, Stockholm, Sweden-
dc.identifier.affiliationMedical Intensive Care Unit, University Hospital of Lyon, Lyon, France-
dc.identifier.affiliationDepartment of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, B-2650, Edegem, Belgium-
dc.identifier.affiliationGIGA-In Silico Medicine, Université de Liège, B4000, Liège, Belgium-
dc.identifier.affiliationService de Réanimation polyvalente, Hôpital Louis Pasteur, CH de Chartres, 28000, Chartres, France-
dc.type.austinJournal Article-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Feb 29, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.